Back
Corbus Pharmaceuticals Holdings Vs. Denali Therapeutics Industry Stock Comparison
Sell
39
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
18.75
Seasonality Move:
54.68%
Buy
68
DNLI
Denali Therapeutics
Last Price:
31.31
Seasonality Move:
6.34%
Sell
39
Corbus Pharmaceuticals Holdings (CRBP)
is a Sell
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $18.78. The Score for CRBP is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- CRBP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics a Buy, Sell or Hold?
- The current Denali Therapeutics [DNLI] share price is $31.35. The Score for DNLI is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- DNLI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $18.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRBP is experiencing slight buying pressure.
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $31.35
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.38 | Sell |
| Relative Strength Index (14 RSI): | 41.68 | Sell |
| Chaikin Money Flow: | 81237 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.82 - 19.1) | Buy |
| Bollinger Bands (100): | (24.12 - 58.54) | Sell |
DNLI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.53 | Buy |
| Relative Strength Index (14 RSI): | 68.76 | Buy |
| Chaikin Money Flow: | 648733 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.03 - 28.61) | Buy |
| Bollinger Bands (100): | (22.45 - 28.23) | Buy |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.89 | Buy |
| 20-day SMA: | 17.71 | Buy |
| 50-day SMA: | 29.11 | Sell |
| 200-day SMA: | 39.16 | Sell |
| 8-day EMA: | 18.18 | Buy |
| 20-day EMA: | 19.05 | Sell |
| 50-day EMA: | 26.92 | Sell |
| 200-day EMA: | 33.55 | Sell |
DNLI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.16 | Buy |
| 20-day SMA: | 27.44 | Buy |
| 50-day SMA: | 27.75 | Buy |
| 200-day SMA: | 22.07 | Buy |
| 8-day EMA: | 28.79 | Buy |
| 20-day EMA: | 27.93 | Buy |
| 50-day EMA: | 27.13 | Buy |
| 200-day EMA: | 23.94 | Buy |
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.64 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.94 per share, and a decrease next year of $0.80 per share.
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.40 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.87 per share, and an increase next year of $0.05 per share.
Corbus Pharmaceuticals Holdings Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Denali Therapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||